Lonza said Wednesday morning it is on the hunt for deals to increase its capacity and technology offerings, which comes after ...
The first of two confirmation hearings is now underway for Robert F. Kennedy, Jr. to serve as President Donald Trump’s HHS ...
The Trump administration said on Wednesday it will consider “opportunities to bring greater transparency” to the ...
Zentalis Pharmaceuticals is axing about 40% of its staff and doubling down on advancing its only pipeline candidate as part ...
A Delaware judge issued a split ruling in a bizarre legal squabble over the IPO plans of Aurion Biotech, which should allow ...
Curie.Bio reveals $340M seed fund, Cullinan's zipalertinib succeeds in lung cancer trial, Benchling cuts 10% staff, I-Mab reduces workforce, Regulus shares Phase 1b data, Imvax raises $29M ...
President Donald Trump’s communications and travel freeze at HHS may be part of the reason an upcoming FDA advisory committee ...
FDA expands Ozempic label to include kidney disease benefits in type 2 diabetes patients. Novo Nordisk's drug can now be ...
KFF analysis highlights that ACA marketplace insurers denied 19% of claims. Less than 1% of denials were appealed, and ...
Novo Nordisk is asking a federal appeals court to make haste on its case challenging the Inflation Reduction Act's drug ...
AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate Enhertu is now approved to treat a new subset of breast cancer ...
Compounding facility ProRx Pharmacy Network has received an FDA warning letter over issues with its semaglutide and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback